Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial
SARS-CoV-2 ARCoV mRNA疫苗在中国成年人中的安全性和免疫原性:一项随机、双盲、安慰剂对照的1期临床试验
期刊:Lancet Microbe
影响因子:20.4
doi:10.1016/S2666-5247(21)00280-9
Chen, Gui-Ling; Li, Xiao-Feng; Dai, Xia-Hong; Li, Nan; Cheng, Meng-Li; Huang, Zhen; Shen, Jian; Ge, Yu-Hua; Shen, Zhen-Wei; Deng, Yong-Qiang; Yang, Shu-Yuan; Zhao, Hui; Zhang, Na-Na; Zhang, Yi-Fei; Wei, Ling; Wu, Kai-Qi; Zhu, Meng-Fei; Peng, Cong-Gao; Jiang, Qi; Cao, Shou-Chun; Li, Yu-Hua; Zhao, Dan-Hua; Wu, Xiao-Hong; Ni, Ling; Shen, Hua-Hao; Dong, Chen; Ying, Bo; Sheng, Guo-Ping; Qin, Cheng-Feng; Gao, Hai-Nv; Li, Lan-Juan